田中 真之

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Pancreaticoduodenectomy 71%
3. Splenic Vein 35%
4. Portal Vein 29%
5. Neoplasms 28%
6. Pancreatic Intraductal Neoplasms 27%
7. Liver 25%
8. Neoplasm Metastasis 22%
9. Portal Hypertension 22%
10. Induction Chemotherapy 20%
11. Survival 19%
12. Living Donors 18%
13. Superior Mesenteric Artery 18%
14. Recurrence 17%
15. Hepatectomy 16%
16. dehydroxymethylepoxyquinomicin 15%
17. Liver Transplantation 15%
18. Neoadjuvant Therapy 14%
19. Meta-Analysis 14%
20. Bile 13%
21. Erythropoietic Protoporphyria 13%
22. Polycystic liver disease 13%
23. Systematic Reviews 13%
24. Basiliximab 12%
25. Acute Liver Failure 12%
26. High Mobility Group Proteins 12%
27. Klatskin Tumor 12%
28. Endoscopic Ultrasound-Guided Fine Needle Aspiration 11%
29. Pancreatectomy 11%
30. Odds Ratio 11%
31. Christianity 11%
32. Pancreatic Juice 11%
33. Exocrine Pancreatic Insufficiency 11%
34. Adenocarcinoma 11%
35. HMGB1 Protein 11%
36. Pancreatic Fistula 11%
37. Lymph Nodes 10%
38. Gastrointestinal Hemorrhage 10%
39. Pancreatic Carcinoma 10%
40. Indocyanine Green 9%
41. Induced Pluripotent Stem Cells 9%
42. Neuroendocrine Tumors 9%
43. Optical Imaging 9%
44. Enteral Nutrition 9%
45. Bile Ducts 8%
46. Gallbladder 8%
47. Varicose Veins 8%
48. Hepatocytes 8%
49. Surgical Instruments 8%
50. Intravenous Administration 7%